Dual-Task Performance in GBA Parkinson’s Disease

Dual-Task Performance in GBA Parkinson’s Disease

Introduction. Parkinson’s disease patients carrying a heterozygous mutation in the gene glucocerebrosidase (GBA-PD) show faster motor and cognitive decline than idiopathic Parkinson’s disease (iPD) patients, but the mechanisms behind this observation are not well understood. Successful dual tasking...

Full description

Bibliographic Details
Main Authors:	Karin Srulijes, Kathrin Brockmann, Senait Ogbamicael, Markus A. Hobert, Ann-Kathrin Hauser, Claudia Schulte, Jasmin Fritzen, Michael Schwenk, Thomas Gasser, Daniela Berg, Walter Maetzler
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2017/8582740

Similar Items

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Gait Is Associated with Cognitive Flexibility: A Dual-Tasking Study in Healthy Older People
by: Markus A. Hobert, et al.
Published: (2017-05-01)

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease
by: Eva Schaeffer, et al.
Published: (2019-06-01)

GBA mutations and Parkinson's disease in Brazil
by: Carlos R. M. Rieder

Poor trail making test performance is directly associated with altered dual task prioritization in the elderly--baseline results from the TREND study.
by: Markus A Hobert, et al.
Published: (2011-01-01)

Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
by: Markus A. Hobert, et al.
Published: (2019-02-01)

Dual vs. Single Tasking During Circular Walking: What Better Reflects Progression in Parkinson's Disease?
by: M. Encarna Micó-Amigo, et al.
Published: (2019-05-01)

Limited effect of dopaminergic medication on straight walking and turning in early to moderate Parkinson’s disease during single and dual tasking
by: Morad eElshehabi, et al.
Published: (2016-01-01)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
by: Seung Pil Yun, et al.
Published: (2018-01-01)

The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
by: Lena F. Burbulla, et al.
Published: (2019-12-01)

GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
by: Silvia Jesús, et al.
Published: (2016-01-01)

The Association between E326K of GBA and the Risk of Parkinson’s Disease
by: Yongpan Huang, et al.
Published: (2018-01-01)

A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson’s Disease
by: Yuan Zhang, et al.
Published: (2018-01-01)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
by: Tapan Behl, et al.
Published: (2021-01-01)

Mild parkinsonian signs in the elderly--is there an association with PD? Crossectional findings in 992 individuals.
by: Stefanie Lerche, et al.
Published: (2014-01-01)

Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients
by: Zhiqiang Jiang, et al.
Published: (2020-07-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
by: Tae-Un Han, et al.
Published: (2020-05-01)

Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven Approach
by: Inga Liepelt-Scarfone, et al.
Published: (2012-01-01)

A MOD Player for GBA
by: GE, LIN, et al.
Published: (2010)

Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson’s Disease
by: Zuzanna Tkaczynska, et al.
Published: (2020-03-01)

Behavioral Phenotyping in a Murine Model of <i>GBA1</i>-Associated Parkinson Disease
by: Jenny Do, et al.
Published: (2021-06-01)

Putative second hit rare genetic variants in families with seemingly GBA-associated Parkinson’s disease
by: Muhammad Aslam, et al.
Published: (2021-01-01)

Motor Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease are not Exacerbated by Gba1 Mutation
by: Fitzpatrick, Megan E.
Published: (2017)

Exploring a Role for the Parkinson Disease-Linked GBA1 Gene in Host Responses to Infections
by: Hake-Volling, Quinton
Published: (2021)

Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
by: Soojin Kim, et al.
Published: (2021-03-01)

Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
by: Pascale Baden, et al.
Published: (2019-07-01)

Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
by: Elisa Menozzi, et al.
Published: (2021-06-01)

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease
by: Haidar Alzaid, et al.
Published: (2020-08-01)

Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
by: Linda Haertner, et al.
Published: (2018-03-01)

Dual Task Performance in Parkinson’s Disease
by: Jennifer A. Foley, et al.
Published: (2013-01-01)

Cholinergic Pathway SNPs and Postural Control in 477 Older Adults
by: Carina Arnold, et al.
Published: (2018-09-01)

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
by: Rafael Franco, et al.
Published: (2018-06-01)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
by: Karen Nuytemans, et al.
Published: (2020-11-01)

Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis
by: Yuan Zhang, et al.
Published: (2018-02-01)

Effect of GBA Mutations on Phenotype of Parkinson’s Disease: A Study on Chinese Population and a Meta-Analysis
by: Yuan Zhang, et al.
Published: (2015-01-01)

<i>GBA</i>, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
by: Giulietta M. Riboldi, et al.
Published: (2019-04-01)

G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome
by: Claudia Ledda, et al.
Published: (2021-09-01)

White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
by: Jennifer Sartor, et al.
Published: (2017-06-01)

Corrigendum: White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
by: Jennifer Sartor, et al.
Published: (2017-10-01)

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
by: Silvia Cerri, et al.
Published: (2021-02-01)